Fluoxetine reduces murine graft-versus-host disease by induction of t cell immunosuppression

Journal of Neuroimmune Pharmacology

Volumn 8, Issue 4, 2013, Pages 934-943

  Gobin, Veerle ^a   Van Steendam, Katleen ^a   Fevery, Sabine ^b   Tilleman, Kelly ^a   Billiau, An D ^b   Denys, Damiaan ^c,d   Deforce, Dieter L ^a  

^a GHENT UNIVERSITY   (Belgium)

^b UNIVERSITY OF LEUVEN   (Belgium)

^c UNIVERSITY OF AMSTERDAM   (Netherlands)

^d NETHERLANDS INSTITUTE FOR NEUROSCIENCE   (Netherlands)

Author keywords

Fluoxetine; Graft versus host disease; Immunosuppression; Serotonin reuptake inhibitors; T cells

Indexed keywords

CITALOPRAM; FLUOXETINE; FLUVOXAMINE; IMMUNOSUPPRESSIVE AGENT; PAROXETINE; SERTRALINE; VENLAFAXINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIPROLIFERATIVE ACTIVITY; APOPTOSIS; ARTICLE; BONE MARROW; BONE TRANSPLANTATION; CELL EXPANSION; CELL VIABILITY; CONTROLLED STUDY; DRUG MEGADOSE; FEMALE; GRAFT VERSUS HOST REACTION; HUMAN; HUMAN CELL; IMMUNOSUPPRESSIVE TREATMENT; IN VITRO STUDY; IN VIVO STUDY; LYMPHOCYTE PROLIFERATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; SURVIVAL; T LYMPHOCYTE;

ANIMALS; BONE MARROW TRANSPLANTATION; FEMALE; FLUOXETINE; GRAFT VS HOST DISEASE; HUMANS; IMMUNOSUPPRESSIVE AGENTS; LEUKOCYTES, MONONUCLEAR; MICE; MICE, INBRED AKR; MICE, INBRED C3H; SEROTONIN UPTAKE INHIBITORS; T-LYMPHOCYTES;

EID: 84882256128     PISSN: 15571890     EISSN: 15571904     Source Type: Journal    
DOI: 10.1007/s11481-013-9463-7     Document Type: Article

References (43)

1. Anderson GM, Bennett AJ, Weld KP, Pushkas JG, Ocame DM, Higley JD (2002) Serotonin in cisternal cerebrospinal fluid of rhesus monkeys: basal levels and effects of sertraline administration. Psychopharmacol (Berl) 161(1):95-99. doi: 10.1007/s00213-002-1034-1
2. Antin JH, Ferrara JL (1992) Cytokine dysregulation and acute graft-versus-host disease. Blood 80(12):2964-2968
3. Barbey JT, Roose SP (1998) SSRI safety in overdose. J Clin Psychiatr 59(Suppl 15):42-48
4. Berkeley MB, Daussin S, Hernandez MC, Bayer BM (1994) In vitro effects of cocaine, lidocaine and monoamine uptake inhibitors on lymphocyte proliferative responses. Immunopharmacol Immunotoxicol 16(2):165-178. doi: 10.3109/08923979409007088
5. Billiau AD, Sefrioui H, Overbergh L, Rutgeerts O, Goebels J, Mathieu C, Waer M (2001) Transforming growth factor-beta inhibits lymphokine activated killer cytotoxicity of bone marrow cells: implications for the graft-versus-leukemia effect in irradiation allogeneic bone marrow chimeras. Transplantation 71(2):292-299
6. Billiau AD, Fevery S, Rutgeerts O, Landuyt W, Waer M (2002) Crucial role of timing of donor lymphocyte infusion in generating dissociated graft-versus-host and graft-versus-leukemia responses in mice receiving allogeneic bone marrow transplants. Blood 100(5):1894-1902. doi: 10.1182/blood-2002-02-0419
7. Cloonan SM, Drozgowska A, Fayne D, Williams DC (2010) The antidepressants maprotiline and fluoxetine have potent selective antiproliferative effects against Burkitt lymphoma independently of the norepinephrine and serotonin transporters. Leuk Lymphoma 51(3):523-539. doi: 10.3109/10428190903552112
8. Denys D, Kavelaars A, Heijnen CJ, Westenberg H (2002) A case of venlafaxine-induced inhibition of T-lymphocyte proliferation. Psychopharmacol (Berl) 164(4):432
9. Diamond M, Kelly JP, Connor TJ (2006) Antidepressants suppress production of the Th1 cytokine interferon-gamma, independent of monoamine transporter blockade. Eur Neuropsychopharmacol 16(7):481-490. doi: 10.1016/j.euroneuro.2005. 11.011
10. Dulawa SC, Holick KA, Gundersen B, Hen R (2004) Effects of chronic fluoxetine in animal models of anxiety and depression. Neuropsychopharmacology 29(7):1321-1330. doi: 10.1038/sj.npp.1300433
11. Edgar VA, Genaro AM, Cremaschi G, Sterin-Borda L (1998) Fluoxetine action on murine T-lymphocyte proliferation: participation of PKC activation and calcium mobilisation. Cell Signal 10(10):721-726
12. Edgar VA, Sterin-Borda L, Cremaschi GA, Genaro AM (1999) Role of protein kinase C and cAMP in fluoxetine effects on human T-cell proliferation. Eur J Pharmacol 372(1):65-73
13. Faraj BA, Olkowski ZL, Jackson RT (1994) Expression of a high-affinity serotonin transporter in human lymphocytes. Int J Immunopharmacol 16(7):561-567
14. Fazzino F, Montes C, Urbina M, Carreira I, Lima L (2008) Serotonin transporter is differentially localized in subpopulations of lymphocytes of major depression patients. Effect of fluoxetine on proliferation. J Neuroimmunol 196(1-2):173-180
15. Fevery S, Billiau AD, Sprangers B, Rutgeerts O, Lenaerts C, Goebels J, Landuyt W, Kasran A, Boon L, Sagaert X, De Wolf-Peeters C, Waer M, Vandenberghe P (2007) CTLA-4 blockade in murine bone marrow chimeras induces a host-derived antileukemic effect without graft-versus-host disease. Leukemia 21(7):1451-1459. doi: 10.1038/sj.leu.2404720
16. Holladay JW, Dewey MJ, Yoo SD (1997) Quantification of fluoxetine and norfluoxetine serum levels by reversed-phase high-performance liquid chromatography with ultraviolet detection. J Chromatogr B: Biomed Sci Appl 704(1-2):259-263
17. Hughes J, Lunn B, O'Brien J (1999) SSRIs and patient groups with specific treatment problems. In: Stanford SC (ed) Selective Serotonin Reuptake Inhibitors (SSRIs). Past, Present and Future. RG Landes, Austin, pp 47-64
18. Hurley CK, Fernandez Vina M, Setterholm M (2003) Maximizing optimal hematopoietic stem cell donor selection from registries of unrelated adult volunteers. Tissue Antigens 61(6):415-424
19. Johnson BD, McCabe C, Hanke CA, Truitt RL (1995) Use of anti-CD3 epsilon F(ab')2 fragments in vivo to modulate graft-versus-host disease without loss of graft-versus-leukemia reactivity after MHC-matched bone marrow transplantation. J Immunol 154(10):5542-5554
20. Kenis G, Steinbusch H, De Baets M, Maes M (2003) Influence of antidepressants on intracellular levels of cyclic adenosine monophosphate in human peripheral blood mononuclear cells. Eur Neuropsychopharmacol 13(1):53-56
21. Kubera M, Lin AH, Kenis G, Bosmans E, van Bockstaele D, Maes M (2001) Anti-Inflammatory effects of antidepressants through suppression of the interferon-gamma/interleukin-10 production ratio. J Clin Psychopharmacol 21(2):199-206
22. Kubera M, Curzytek K, Majewska-Szczepanik M, Szczepanik M, Marcinska K, Ptak W, Leskiewicz M, Maes M, Basta-Kaim A, Budziszewska B, Detka J, Duda W, Lason W (2012) Inhibitory effect of antidepressant drugs on contact hypersensitivity reaction. Pharmacol Rep 64(3):714-722
23. Maes M, Song C, Lin AH, Bonaccorso S, Kenis G, De Jongh R, Bosmans E, Scharpe S (1999) Negative immunoregulatory effects of antidepressants: inhibition of interferon-gamma and stimulation of interleukin-10 secretion. Neuropsychopharmacology 20(4):370-379. doi: 10.1016/S0893-133X(98)00088-8
24. Maes M, Kenis G, Kubera M, De Baets M, Steinbusch H, Bosmans E (2005) The negative immunoregulatory effects of fluoxetine in relation to the cAMP-dependent PKA pathway. Int Immunopharmacol 5(3):609-618. doi: 10.1016/j.intimp.2004.11.008
25. Miconnet I, Roger T, Seman M, Bruley-Rosset M (1995) Critical role of endogenous Mtv in acute lethal graft-versus-host disease. Eur J Immunol 25(2):364-368. doi: 10.1002/eji.1830250209
26. Pellegrino TC, Bayer BM (1998) Modulation of immune cell function following fluoxetine administration in rats. Pharmacol Biochem Behav 59(1):151-157
27. Pellegrino TC, Bayer BM (2000) Specific serotonin reuptake inhibitor-induced decreases in lymphocyte activity require endogenous serotonin release. Neuroimmunomodulation 8(4):179-187
28. Reed SM, Glick JW (1991) Fluoxetine and reactivation of the herpes simplex virus. Am J Psychiatry 148(7):949-950
29. Roederer M (2011) Interpretation of cellular proliferation data: avoid the Panglossian. Cytometry Part A 79A(2):95-101. doi: 10.1002/cyto.a.21010
30. Roumestan C, Michel A, Bichon F, Portet K, Detoc M, Henriquet C, Jaffuel D, Mathieu M (2007) Anti-inflammatory properties of desipramine and fluoxetine. Respir Res 8:35. doi: 10.1186/1465-9921-8-35
31. Sacre S, Medghalchi M, Gregory B, Brennan F, Williams R (2010) Fluoxetine and citalopram exhibit potent antiinflammatory activity in human and murine models of rheumatoid arthritis and inhibit toll-like receptors. Arthritis Rheum 62(3):683-693
32. Sanchez C (2006) The pharmacology of citalopram enantiomers: the antagonism by R-citalopram on the effect of S-citalopram. Basic Clin Pharmacol Toxicol 99(2):91-95. doi: 10.1111/j.1742-7843.2006.pto-295.x
33. Sefrioui H, Billiau AD, Waer M (2000) Graft-versus-leukemia effect in minor antigen mismatched chimeras given delayed donor leucocyte infusion: immunoregulatory aspects and role of donor T and ASGM1-positive cells. Transplantation 70(2):348-353
34. Serafeim A, Grafton G, Chamba A, Gregory CD, Blakely RD, Bowery NG, Barnes NM, Gordon J (2002) 5-Hydroxytryptamine drives apoptosis in biopsylike Burkitt lymphoma cells: reversal by selective serotonin reuptake inhibitors. Blood 99(7):2545-2553
35. Taler M, Gil-Ad I, Lomnitski L, Korov I, Baharav E, Bar M, Zolokov A, Weizman A (2007) Immunomodulatory effect of selective serotonin reuptake inhibitors (SSRIs) on human T lymphocyte function and gene expression. Eur Neuropsychopharmacol 17(12):774-780
36. Taler M, Bar M, Korob I, Lomnitski L, Baharav E, Grunbaum-Novak N, Weizman A, Gil-Ad I (2008) Evidence for an inhibitory immunomodulatory effect of selected antidepressants on rat splenocytes: possible relevance to depression and hyperactive-immune disorders. Int Immunopharmacol 8(4):526-533
37. Taler M, Gil-Ad I, Korob I, Weizman A (2011) The immunomodulatory effect of the antidepressant sertraline in an experimental autoimmune encephalomyelitis mouse model of multiple sclerosis. Neuroimmunomodulation 18(2):117-122. doi: 10.1159/000321634
38. Tatsumi M, Groshan K, Blakely RD, Richelson E (1997) Pharmacological profile of antidepressants and related compounds at human monoamine transporters. Eur J Pharmacol 340(2-3):249-258
39. Vaswani M, Linda FK, Ramesh S (2003) Role of selective serotonin reuptake inhibitors in psychiatric disorders: a comprehensive review. Prog Neuropsychopharmacol Biol Psychiatry 27(1):85-102
40. Vollmar P, Nessler S, Kalluri SR, Hartung HP, Hemmer B (2009) The antidepressant venlafaxine ameliorates murine experimental autoimmune encephalomyelitis by suppression of pro-inflammatory cytokines. Int J Neuropsychopharmacol 12(4):525-536
41. Xia Z, DePierre JW, Nassberger L (1996) Tricyclic antidepressants inhibit IL-6, IL-1 beta and TNF-alpha release in human blood monocytes and IL-2 and interferon-gamma in T cells. Immunopharmacology 34(1):27-37
42. Xia Z, Karlsson H, DePierre JW, Nassberger L (1997) Tricyclic antidepressants induce apoptosis in human T lymphocytes. Int J Immunopharmacol 19(11-12):645-654
43. Yuan XQ, Qiu G, Liu XJ, Liu S, Wu YM, Wang XY, Lu TM (2012) Fluoxetine promotes remission in acute experimental autoimmune encephalomyelitis in rats. Neuroimmunomodulation 19(4):201-208. doi: 10.1159/000334095